{
    "clinical_study": {
        "@rank": "41788", 
        "acronym": "GRAFFITI", 
        "arm_group": [
            {
                "arm_group_label": "Angio-guided arm", 
                "arm_group_type": "Active Comparator", 
                "description": "In this arm will be included the patient randomized to a Angiography-guided surgical revascularization strategy."
            }, 
            {
                "arm_group_label": "FFR-guided arm", 
                "arm_group_type": "Experimental", 
                "description": "In this arm will be included the patient randomized to a FFR-guided surgical revascularization strategy."
            }
        ], 
        "brief_summary": {
            "textblock": "This is prospective, randomized, multicenter, multinational, randomized (1:1) study. The aim\n      of this study is to assess the importance of functional assessment of coronary artery\n      disease prior to bypass surgery. In particular, an FFR-guided strategy will be compared to\n      the traditional Angio-guided strategy in the guidance of surgical revascularization by\n      aorto-coronary bypass grafting."
        }, 
        "brief_title": "Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial", 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with stable angina, unstable angina or NSTEMI candidate to CABG\n\n          -  Significant LAD and/or LM lesion - proved by FFR or Angiography AND\n\n          -  At least one more, angiographycally intermediate lesion\n\n        Exclusion Criteria:\n\n          -  Significant valvular disease with indication to surgical replacement\n\n          -  Severe left ventricular dysfunction (EF<35%)\n\n          -  Acute STEMI\n\n          -  Atrial fibrillation, if Maze procedure is planned"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "206", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01810224", 
            "org_study_id": "GRAFFITI"
        }, 
        "intervention": {
            "arm_group_label": [
                "Angio-guided arm", 
                "FFR-guided arm"
            ], 
            "description": "The final intervention (surgical revascularization) will be the same for both arms.", 
            "intervention_name": "Surgical revascularization", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 11, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium", 
                        "zip": "9300"
                    }, 
                    "name": "Cardiovascular Center Aalst OLV Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Emanuele Barbato, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Bernard De Bruyne, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gabor Toth, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kalapetr7@gmail.com", 
                    "last_name": "Petr Kala, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Department of Internal Medicine and Cardiology, University Hospital Brno"
                }, 
                "investigator": {
                    "last_name": "Petr Kala, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "piroth@freemail.hu", 
                    "last_name": "Zsolt Piroth"
                }, 
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary"
                    }, 
                    "name": "Hungarian Institute of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Zsolt Piroth, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Czech Republic", 
                "Hungary"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial", 
        "overall_contact": {
            "email": "emanuele.barbato@olvz-aalst.be", 
            "last_name": "Emanuele Barbato, MD, PhD"
        }, 
        "overall_official": {
            "affiliation": "Cardiovascular Center Aalst, OLV Hospital, Aalst (Belgium)", 
            "last_name": "Emanuele Barbato, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of occluded bypass grafts", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01810224"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Onze Lieve Vrouw  Hospital", 
            "investigator_full_name": "Emanuele Barbato", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "a) Lenght of hospital stay; b) Changes in surgical strategy: i.e. open-chest surgery vs. mini-thoracotomy; extensive surgery versus minimal invasive approaches.", 
            "safety_issue": "Yes", 
            "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 3-4 weeks"
        }, 
        "source": "Onze Lieve Vrouw  Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Onze Lieve Vrouw  Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}